SGA 9184
In CommitteeSenate
HAWKINS B. DEFRANCE
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill formally appoints Hawkins B. DeFrance to the Pharmacy Quality Assurance Commission, effective December 4, 2024, for a fixed term ending January 19, 2028.
- Appoints Hawkins B. DeFrance as a member of the Pharmacy Quality Assurance Commission.
- Sets the term of service to end on January 19, 2028.
Who is affected
- Hawkins B. DeFrance — The individual named, Hawkins B. DeFrance, is appointed to serve as a member of the Pharmacy Quality Assurance Commission.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (1)
This bill ensures continuity and stability in pharmacy regulation by formally appointing a qualified individual to a state oversight body responsible for licensing, discipline, and quality assurance for pharmacists and pharmacies — a function critical to public health and consumer protection.
Local GovernmentRef: Appoints Hawkins B. DeFrance as a Member of the Pharmacy Quality Assurance Commission
Who Is Most Affected
Hawkins B. DeFrance gains formal authority and responsibility to participate in regulatory decisions affecting pharmacy practice, including licensing, enforcement, and policy development — a position of professional influence and public trust.
The Pharmacy Quality Assurance Commission benefits from having a full complement of members, improving its capacity to carry out its statutory duties, including oversight of drug distribution, prescription accuracy, and patient safety.
Washingtonians benefit indirectly from consistent, high-quality pharmacy oversight — including reduced medication errors, enforcement of standards, and accountability for drug dispensing practices.
Pharmacists and pharmacy operators remain subject to the same regulatory framework; this appointment does not alter rules or enforcement priorities, but ensures the commission has quorum to act.
State government operations continue as usual; no fiscal or structural change is triggered by this appointment, as the position is already authorized and funded.